Himmel's Gold Bond limited superiority claim substantiated in NAD review.
This article was originally published in The Tan Sheet
Executive Summary
HIMMEL GOLD BOND ITCH RELIEF SUPERIORITY AT 10 MINUTES SUBSTANTIATED for use in ad claims, the National Advertising Division of the Council of Better Business Bureaus ruled in a case report published Feb. 8. NAD disagreed with a challenge from Combe, Inc., marketer of Lanacane Anesthetic Creme Medication. The watchdog organization concluded that "based on its comparative medical itch testing, the advertiser had a reasonable basis" for claiming that Gold Bond provides more effective itch relief at 10 minutes after application.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning